vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and HEALTHY CHOICE WELLNESS CORP. (HCWC). Click either name above to swap in a different company.
Autolus Therapeutics plc is the larger business by last-quarter revenue ($21.2M vs $18.7M, roughly 1.1× HEALTHY CHOICE WELLNESS CORP.). HEALTHY CHOICE WELLNESS CORP. runs the higher net margin — -8.9% vs -373.3%, a 364.4% gap on every dollar of revenue. HEALTHY CHOICE WELLNESS CORP. produced more free cash flow last quarter ($-927.1K vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
AUTL vs HCWC — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $21.2M | $18.7M |
| Net Profit | $-79.1M | $-1.7M |
| Gross Margin | — | 39.1% |
| Operating Margin | -337.9% | -7.6% |
| Net Margin | -373.3% | -8.9% |
| Revenue YoY | — | — |
| Net Profit YoY | 3.6% | — |
| EPS (diluted) | $-0.30 | $-0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $18.7M | ||
| Q3 25 | $21.2M | $19.0M | ||
| Q2 25 | $20.9M | $20.2M | ||
| Q1 25 | $9.0M | $20.3M | ||
| Q3 24 | $0 | $18.2M | ||
| Q2 24 | $0 | — | ||
| Q1 24 | $10.1M | — |
| Q4 25 | — | $-1.7M | ||
| Q3 25 | $-79.1M | $-1.2M | ||
| Q2 25 | $-47.9M | $-339.4K | ||
| Q1 25 | $-70.2M | $-712.4K | ||
| Q3 24 | $-82.1M | $-2.7M | ||
| Q2 24 | $-58.3M | — | ||
| Q1 24 | $-52.7M | — |
| Q4 25 | — | 39.1% | ||
| Q3 25 | — | 38.8% | ||
| Q2 25 | — | 40.1% | ||
| Q1 25 | — | 38.8% | ||
| Q3 24 | — | 38.4% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -7.6% | ||
| Q3 25 | -337.9% | -3.2% | ||
| Q2 25 | -292.6% | -0.2% | ||
| Q1 25 | -726.3% | -2.0% | ||
| Q3 24 | — | -2.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | -384.1% | — |
| Q4 25 | — | -8.9% | ||
| Q3 25 | -373.3% | -6.4% | ||
| Q2 25 | -229.0% | -1.7% | ||
| Q1 25 | -781.1% | -3.5% | ||
| Q3 24 | — | -14.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | -522.1% | — |
| Q4 25 | — | $-0.05 | ||
| Q3 25 | $-0.30 | $-0.09 | ||
| Q2 25 | $-0.18 | $-0.03 | ||
| Q1 25 | $-0.26 | $-0.07 | ||
| Q3 24 | $-0.31 | $-0.29 | ||
| Q2 24 | $-0.22 | — | ||
| Q1 24 | $-0.24 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $3.0M |
| Total DebtLower is stronger | — | $7.3M |
| Stockholders' EquityBook value | $265.5M | $7.3M |
| Total Assets | $661.9M | $33.5M |
| Debt / EquityLower = less leverage | — | 1.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.0M | ||
| Q3 25 | $86.1M | $3.0M | ||
| Q2 25 | $123.8M | $4.7M | ||
| Q1 25 | $95.8M | $1.8M | ||
| Q3 24 | $657.1M | $1.8M | ||
| Q2 24 | $705.9M | — | ||
| Q1 24 | $758.5M | — |
| Q4 25 | — | $7.3M | ||
| Q3 25 | — | $8.5M | ||
| Q2 25 | — | $9.7M | ||
| Q1 25 | — | $10.6M | ||
| Q3 24 | — | $11.6M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $7.3M | ||
| Q3 25 | $265.5M | $5.9M | ||
| Q2 25 | $346.5M | $5.8M | ||
| Q1 25 | $371.1M | $2.1M | ||
| Q3 24 | $477.0M | $2.9M | ||
| Q2 24 | $527.8M | — | ||
| Q1 24 | $582.0M | — |
| Q4 25 | — | $33.5M | ||
| Q3 25 | $661.9M | $33.7M | ||
| Q2 25 | $721.0M | $36.4M | ||
| Q1 25 | $746.3M | $34.1M | ||
| Q3 24 | $827.5M | $33.2M | ||
| Q2 24 | $853.6M | — | ||
| Q1 24 | $901.4M | — |
| Q4 25 | — | 1.00× | ||
| Q3 25 | — | 1.43× | ||
| Q2 25 | — | 1.69× | ||
| Q1 25 | — | 5.01× | ||
| Q3 24 | — | 3.95× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $-855.1K |
| Free Cash FlowOCF − Capex | $-72.3M | $-927.1K |
| FCF MarginFCF / Revenue | -341.2% | -5.0% |
| Capex IntensityCapex / Revenue | 20.8% | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $675.4K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-855.1K | ||
| Q3 25 | $-67.9M | $-308.7K | ||
| Q2 25 | $-72.8M | $1.1M | ||
| Q1 25 | $-75.6M | $1.1M | ||
| Q3 24 | $-76.7M | — | ||
| Q2 24 | $-51.1M | — | ||
| Q1 24 | $-40.5M | — |
| Q4 25 | — | $-927.1K | ||
| Q3 25 | $-72.3M | $-351.3K | ||
| Q2 25 | $-80.1M | $988.6K | ||
| Q1 25 | $-83.8M | $965.3K | ||
| Q3 24 | $-86.3M | — | ||
| Q2 24 | $-51.9M | — | ||
| Q1 24 | $-41.0M | — |
| Q4 25 | — | -5.0% | ||
| Q3 25 | -341.2% | -1.8% | ||
| Q2 25 | -382.6% | 4.9% | ||
| Q1 25 | -933.1% | 4.8% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -406.8% | — |
| Q4 25 | — | 0.4% | ||
| Q3 25 | 20.8% | 0.2% | ||
| Q2 25 | 34.8% | 0.4% | ||
| Q1 25 | 91.8% | 0.6% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.3% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AUTL
Segment breakdown not available.
HCWC
| Retail Grocery | $17.1M | 91% |
| Food Service Restaurant | $1.7M | 9% |